MDxHealth SA Files 6-K, Incorporates Exhibits into F-3
Ticker: MDXH · Form: 6-K · Filed: Sep 30, 2024 · CIK: 1872529
| Field | Detail |
|---|---|
| Company | Mdxhealth SA (MDXH) |
| Form Type | 6-K |
| Filed Date | Sep 30, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $37.3 m, $42.5 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
MDxHealth SA filed a 6-K on 9/30, incorporating docs into their F-3. Standard reporting.
AI Summary
MDxHealth SA filed a Form 6-K on September 30, 2024, reporting information for the month of September 2024. The filing incorporates by reference several exhibits into its existing Form F-3 registration statement (Registration Statement No. 333-268885). The company is incorporated in Belgium and its principal executive office is located in Herstal.
Why It Matters
This filing updates the company's disclosures and incorporates information into its existing registration statement, which is relevant for investors tracking ongoing reporting requirements and potential future offerings.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer and does not appear to contain significant new financial or operational information that would immediately impact the company's risk profile.
Key Numbers
- 001-40996 — Commission File Number (Identifies the company's filing with the SEC.)
- 333-268885 — Registration Statement Number (Refers to the company's Form F-3 registration statement.)
Key Players & Entities
- MDxHealth SA (company) — Registrant
- 333-268885 (dollar_amount) — Form F-3 Registration Statement Number
- September 2024 (date) — Reporting period
- 001-40996 (dollar_amount) — Commission File Number
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a report of foreign private issuer filed for the month of September 2024, and it incorporates by reference several exhibits into the company's existing Form F-3 registration statement.
What is the company's full name and location?
The company's name is MDxHEALTH SA, and its principal executive office is located at CAP Business Center Zone Industrielle des Hauts-Sarts 4040 Herstal, Belgium.
Does MDxHealth SA file annual reports under Form 20-F or 40-F?
Yes, MDxHealth SA files annual reports under cover of Form 20-F.
What is the Commission File Number for MDxHealth SA?
The Commission File Number for MDxHealth SA is 001-40996.
Which registration statement is being referenced in this filing?
The filing incorporates exhibits into the registration statement on Form F-3, with Registration Statement No. 333-268885.
Filing Stats: 765 words · 3 min read · ~3 pages · Grade level 11.3 · Accepted 2024-09-30 16:05:03
Key Financial Figures
- $37.3 m — fering are expected to be approximately $37.3 million, or $42.5 million if the Underwri
- $42.5 million — d to be approximately $37.3 million, or $42.5 million if the Underwriters exercise their opti
Filing Documents
- ea0215879-6k_mdx.htm (6-K) — 17KB
- ea021587901ex1-1_mdx.htm (EX-1.1) — 258KB
- ea021587901ex3-1_mdx.htm (EX-3.1) — 177KB
- ea021587901ex5-1_mdx.htm (EX-5.1) — 108KB
- ea021587901ex99-1_mdx.htm (EX-99.1) — 54KB
- ea021587901ex99-2_mdx.htm (EX-99.2) — 10KB
- ea021587901ex99-3_mdx.htm (EX-99.3) — 11KB
- ex5-1_001.jpg (GRAPHIC) — 7KB
- ex5-1_002.jpg (GRAPHIC) — 3KB
- ex99-2_001.jpg (GRAPHIC) — 6KB
- ex99-3_001.jpg (GRAPHIC) — 6KB
- 0001213900-24-083354.txt ( ) — 667KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MDXHEALTH SA Date: September 30, 2024 By: /s/ Michael McGarrity Name: Michael McGarrity Title: Chief Executive Officer 2